AI Tokens
Stock Analysis on Net

CVS Health Corp. (NYSE:CVS)

This company has been moved to the archive! The financial data has not been updated since May 1, 2025.

Analysis of Goodwill and Intangible Assets

Microsoft Excel

Goodwill and Intangible Asset Disclosure

CVS Health Corp., balance sheet: goodwill and intangible assets

US$ in millions

Microsoft Excel
Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Goodwill 91,272 91,272 78,150 79,121 79,552
Trademark 10,498 10,498 10,498 10,498 10,498
Indefinitely-lived intangible assets 10,498 10,498 10,498 10,498 10,498
Customer contracts/relationships and covenants not to compete 26,904 26,784 21,206 25,084 24,952
Technology 1,250 1,253 1,060 1,060 1,060
Provider networks 4,203 4,203 4,203 4,203 4,203
Value of Business Acquired 590 590 590 590 590
Other 826 838 302 318 320
Finitely-lived intangible assets, gross carrying amount 33,773 33,668 27,361 31,255 31,125
Accumulated amortization (16,948) (14,932) (13,077) (12,727) (10,481)
Finitely-lived intangible assets, net carrying amount 16,825 18,736 14,284 18,528 20,644
Intangible assets 27,323 29,234 24,782 29,026 31,142
Goodwill and other intangibles 118,595 120,506 102,932 108,147 110,694

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).


The financial trajectory of goodwill and intangible assets exhibits a period of gradual decline followed by a significant increase in 2023, with a slight correction occurring in 2024. Total goodwill and other intangibles decreased from 110,694 million USD in 2020 to 102,932 million USD in 2022, before rising sharply to 120,506 million USD in 2023 and settling at 118,595 million USD by the end of 2024.

Goodwill Analysis
Goodwill remained relatively stable between 2020 and 2022, with a slight downward trend. However, a substantial increase occurred in 2023, where the value rose from 78,150 million USD to 91,272 million USD. This value remained unchanged through December 31, 2024, indicating a significant capital allocation toward acquisitions during the 2023 fiscal year.
Indefinitely-Lived Intangible Assets
Trademarks and other indefinitely-lived intangible assets remained completely static throughout the five-year period, holding constant at 10,498 million USD. This suggests an absence of new brand acquisitions and no impairment charges recognized against these specific assets.
Finitely-Lived Intangible Assets and Amortization
The gross carrying amount of finitely-lived intangible assets showed volatility, dropping to 27,361 million USD in 2022 before increasing to 33,773 million USD by 2024. This volatility is primarily driven by fluctuations in customer contracts, relationships, and covenants not to compete. Concurrently, accumulated amortization showed a consistent and linear increase, growing from -10,481 million USD in 2020 to -16,948 million USD in 2024, which exerted downward pressure on the net carrying amount of these assets.
Asset Composition and Trends
Provider networks remained unchanged at 4,203 million USD, and the value of businesses acquired remained constant at 590 million USD. The net carrying amount of finitely-lived intangible assets peaked in 2023 at 18,736 million USD before declining to 16,825 million USD in 2024, reflecting the ongoing impact of amortization outpacing new asset additions in the final year of the period.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?


Adjustments to Financial Statements: Removal of Goodwill

CVS Health Corp., Financial Data: Reported vs. Adjusted

CVS Health Corp., adjustments to financial statements

US$ in millions

Microsoft Excel
Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Adjustment to Total Assets
Total assets (as reported) 253,215 249,728 228,275 232,999 230,715
Less: Goodwill 91,272 91,272 78,150 79,121 79,552
Total assets (adjusted) 161,943 158,456 150,125 153,878 151,163
Adjustment to Total CVS Health Shareholders’ Equity
Total CVS Health shareholders’ equity (as reported) 75,560 76,461 71,015 75,075 69,389
Less: Goodwill 91,272 91,272 78,150 79,121 79,552
Total CVS Health shareholders’ equity (adjusted) (15,712) (14,811) (7,135) (4,046) (10,163)
Adjustment to Net Income Attributable To CVS Health
Net income attributable to CVS Health (as reported) 4,614 8,344 4,149 7,910 7,179
Add: Goodwill impairment — — — 431 —
Net income attributable to CVS Health (adjusted) 4,614 8,344 4,149 8,341 7,179

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).


An analysis of the financial position from 2020 to 2024 reveals a significant divergence between reported and adjusted financial metrics following the removal of goodwill and intangible assets. While reported assets and equity maintain a positive trajectory or stability, the adjusted figures indicate a fundamentally different capital structure characterized by negative tangible equity.

Asset Composition and Intangible Impact
Reported total assets increased from 230,715 million US dollars in 2020 to 253,215 million US dollars in 2024. However, the adjusted total assets, which exclude goodwill and intangibles, are consistently and substantially lower, ending at 161,943 million US dollars in 2024. The gap between reported and adjusted assets remained relatively stable between 2020 and 2022, before expanding significantly in 2023 and 2024, suggesting an increase in the valuation or acquisition of intangible assets during the latter period.
Tangible Equity and Solvency Analysis
The most critical trend is observed in the shareholders' equity. While reported equity remained positive and relatively stable, fluctuating between 69,389 million US dollars and 76,461 million US dollars, the adjusted equity is consistently negative throughout the five-year period. This negative tangible equity transitioned from -10,163 million US dollars in 2020 to -15,712 million US dollars by 2024. This pattern indicates that the reported equity is entirely dependent on the valuation of goodwill and intangible assets, and the company operates with a negative tangible book value.
Net Income Correlation
Reported and adjusted net income figures are nearly identical across the analyzed period, with a minor variance observed in 2021. This suggests that the adjustments made to remove goodwill and intangible assets are primarily balance sheet corrections and do not involve significant non-cash amortization or impairment charges that would materially alter the net income result on an annual basis.
Overall Financial Trend
A trend of increasing reliance on intangible assets is evident. The widening gap between reported and adjusted equity from 2022 to 2024 suggests that the growth in total assets is not matched by a corresponding growth in tangible equity, thereby deepening the negative adjusted equity position. This reflects a corporate structure where the premium paid for acquisitions and intangible intellectual property far exceeds the tangible net worth of the organization.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?


Adjusted Financial Ratios: Removal of Goodwill (Summary)

CVS Health Corp., Financial Ratios: Reported vs. Adjusted

CVS Health Corp., adjusted financial ratios

Microsoft Excel
Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Net Profit Margin
Reported net profit margin 1.24% 2.34% 1.29% 2.72% 2.68%
Adjusted net profit margin 1.24% 2.34% 1.29% 2.87% 2.68%
Total Asset Turnover
Reported total asset turnover 1.46 1.43 1.41 1.25 1.16
Adjusted total asset turnover 2.29 2.25 2.14 1.89 1.77
Financial Leverage
Reported financial leverage 3.35 3.27 3.21 3.10 3.32
Adjusted financial leverage — — — — —
Return on Equity (ROE)
Reported ROE 6.11% 10.91% 5.84% 10.54% 10.35%
Adjusted ROE — — — — —
Return on Assets (ROA)
Reported ROA 1.82% 3.34% 1.82% 3.39% 3.11%
Adjusted ROA 2.85% 5.27% 2.76% 5.42% 4.75%

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).


The financial analysis reveals a significant divergence between reported and adjusted performance metrics, primarily driven by the exclusion of goodwill and intangible assets. While reported figures reflect the total balance sheet, the adjusted ratios provide a clearer view of operational asset efficiency and core productivity.

Asset Utilization and Efficiency
A consistent upward trend is observed in total asset turnover from 2020 to 2024. Reported turnover increased from 1.16 to 1.46, indicating a steady improvement in the ability to generate revenue from the total asset base. However, the adjusted total asset turnover is substantially higher, rising from 1.77 in 2020 to 2.29 in 2024. This marked difference suggests that a significant portion of the company's assets consists of non-operating intangible assets, and the removal of these items reveals a much higher level of underlying operational efficiency.
Profitability and Return on Assets
The reported return on assets (ROA) exhibited significant volatility, peaking at 3.39% in 2021 and declining to 1.82% in 2024. The adjusted ROA consistently outperforms reported figures across all periods, starting at 4.75% in 2020 and ending at 2.85% in 2024. Although the adjusted ROA follows the same volatile trajectory as the reported ROA—dipping in 2022 and 2024—the absolute values remain higher, demonstrating that the core tangible asset base generates higher relative returns than the total asset base including goodwill.
Net Profit Margin Trends
Net profit margins remained relatively stable between 2020 and 2021 before experiencing a sharp decline in 2022 (1.29%), a partial recovery in 2023 (2.34%), and a subsequent drop to 1.24% in 2024. The minimal variance between reported and adjusted net profit margins indicates that the amortization of intangible assets has a negligible impact on overall bottom-line profitability compared to other operational expenses or revenue fluctuations.
Financial Leverage
Reported financial leverage has remained relatively stable over the five-year period, fluctuating within a narrow range between 3.10 and 3.35. A slight increasing trend is observed toward the end of the period, reaching 3.35 by December 31, 2024, indicating a consistent reliance on debt to finance the asset base.

In summary, the exclusion of goodwill and intangible assets fundamentally alters the perception of the company's efficiency. The substantial gap between reported and adjusted asset turnover and ROA highlights that the company's operational core is significantly more productive than the reported total asset figures suggest, despite the volatility observed in net profit margins.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?


Adjusted Net Profit Margin

Microsoft Excel
Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
As Reported
Selected Financial Data (US$ in millions)
Net income attributable to CVS Health 4,614 8,344 4,149 7,910 7,179
Revenues from customers 370,656 356,623 321,629 290,912 267,908
Profitability Ratio
Net profit margin1 1.24% 2.34% 1.29% 2.72% 2.68%
Adjusted for Goodwill
Selected Financial Data (US$ in millions)
Adjusted net income attributable to CVS Health 4,614 8,344 4,149 8,341 7,179
Revenues from customers 370,656 356,623 321,629 290,912 267,908
Profitability Ratio
Adjusted net profit margin2 1.24% 2.34% 1.29% 2.87% 2.68%

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

2024 Calculations

1 Net profit margin = 100 × Net income attributable to CVS Health ÷ Revenues from customers
= 100 × 4,614 ÷ 370,656 = 1.24%

2 Adjusted net profit margin = 100 × Adjusted net income attributable to CVS Health ÷ Revenues from customers
= 100 × 4,614 ÷ 370,656 = 1.24%


An analysis of the financial performance between 2020 and 2024 reveals significant volatility in both net income and profit margins. The trajectory is characterized by cyclical fluctuations, with notable contractions in 2022 and 2024, interrupted by a recovery in 2023.

Net Income Trends
Reported net income exhibited a non-linear progression, increasing from US$ 7,179 million in 2020 to US$ 7,910 million in 2021, before dropping sharply to US$ 4,149 million in 2022. A substantial recovery occurred in 2023, with income reaching a peak of US$ 8,344 million, followed by another significant decline to US$ 4,614 million in 2024.
Adjusted Net Income Performance
Adjusted net income followed a similar pattern to reported figures, with a divergence occurring specifically in 2021. In that year, adjusted net income was US$ 8,341 million compared to the reported US$ 7,910 million, suggesting the impact of non-recurring items. For 2020, 2022, 2023, and 2024, the adjusted and reported figures remained identical, indicating an absence of significant one-time adjustments in those periods.
Net Profit Margin Volatility
The reported net profit margin fluctuated between a high of 2.72% in 2021 and a low of 1.24% in 2024. A marked compression is observed in 2022 (1.29%) and 2024 (1.24%), while 2023 showed a temporary rebound to 2.34%.
Adjusted Net Profit Margin Analysis
The adjusted net profit margin highlights a peak efficiency in 2021 at 2.87%, which represents the highest profitability point across the five-year period. The subsequent decline in 2022 to 1.29% and the final descent to 1.24% in 2024 indicate a downward trend in overall margin stability, despite the brief recovery seen in 2023.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?


Adjusted Total Asset Turnover

Microsoft Excel
Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
As Reported
Selected Financial Data (US$ in millions)
Revenues from customers 370,656 356,623 321,629 290,912 267,908
Total assets 253,215 249,728 228,275 232,999 230,715
Activity Ratio
Total asset turnover1 1.46 1.43 1.41 1.25 1.16
Adjusted for Goodwill
Selected Financial Data (US$ in millions)
Revenues from customers 370,656 356,623 321,629 290,912 267,908
Adjusted total assets 161,943 158,456 150,125 153,878 151,163
Activity Ratio
Adjusted total asset turnover2 2.29 2.25 2.14 1.89 1.77

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

2024 Calculations

1 Total asset turnover = Revenues from customers ÷ Total assets
= 370,656 ÷ 253,215 = 1.46

2 Adjusted total asset turnover = Revenues from customers ÷ Adjusted total assets
= 370,656 ÷ 161,943 = 2.29


An analysis of the asset base and corresponding turnover ratios reveals a consistent upward trend in operational efficiency from 2020 through 2024. While reported total assets experienced a slight contraction in 2022, the subsequent years demonstrate recovery and expansion, reaching 253,215 million US dollars by the end of 2024.

Asset Composition and Adjustment
A significant variance is maintained between reported total assets and adjusted total assets throughout the five-year period. The adjusted asset base remains substantially lower, indicating a high concentration of goodwill and intangible assets. This gap increased from approximately 79,552 million US dollars in 2020 to 91,272 million US dollars in 2024, reflecting an increase in the absolute value of non-physical assets on the balance sheet.
Reported Asset Turnover Trends
The reported total asset turnover ratio shows a steady improvement, rising from 1.16 in 2020 to 1.46 in 2024. This trend indicates a progressive increase in the ability to generate revenue relative to the entire asset base, including all acquired intangibles.
Adjusted Asset Turnover Trends
The adjusted total asset turnover, which excludes intangible assets, exhibits a more pronounced growth trajectory, increasing from 1.77 in 2020 to 2.29 in 2024. This higher ratio confirms that the core tangible asset base is utilized more intensively to drive revenue than the total reported assets suggest.
Comparative Efficiency Insight
The divergence between reported and adjusted turnover ratios has widened over the observed period. The difference between the two ratios grew from 0.61 in 2020 to 0.83 in 2024. This widening gap underscores the impact of goodwill and intangible assets on the reported efficiency metrics, as the operational tangible assets are generating revenue at a significantly higher rate than the consolidated balance sheet implies.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?


Adjusted Financial Leverage

Microsoft Excel
Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
As Reported
Selected Financial Data (US$ in millions)
Total assets 253,215 249,728 228,275 232,999 230,715
Total CVS Health shareholders’ equity 75,560 76,461 71,015 75,075 69,389
Solvency Ratio
Financial leverage1 3.35 3.27 3.21 3.10 3.32
Adjusted for Goodwill
Selected Financial Data (US$ in millions)
Adjusted total assets 161,943 158,456 150,125 153,878 151,163
Adjusted total CVS Health shareholders’ equity (15,712) (14,811) (7,135) (4,046) (10,163)
Solvency Ratio
Adjusted financial leverage2 — — — — —

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

2024 Calculations

1 Financial leverage = Total assets ÷ Total CVS Health shareholders’ equity
= 253,215 ÷ 75,560 = 3.35

2 Adjusted financial leverage = Adjusted total assets ÷ Adjusted total CVS Health shareholders’ equity
= 161,943 ÷ -15,712 = —


A consistent upward trend is observed in both reported and adjusted total assets from 2020 to 2024. Reported total assets increased from 230,715 million US$ to 253,215 million US$, while adjusted total assets grew from 151,163 million US$ to 161,943 million US$. The significant and persistent variance between these two metrics indicates a high concentration of goodwill and intangible assets within the corporate balance sheet.

A critical divergence exists between reported and adjusted shareholders' equity. Reported equity remained relatively stable and positive, ending the period at 75,560 million US$. Conversely, adjusted shareholders' equity remained negative throughout the entire period and exhibited a deteriorating trend, declining from -10,163 million US$ in 2020 to -15,712 million US$ in 2024. This indicates that the value of goodwill and intangible assets exceeds the total reported equity of the organization.

Reported Financial Leverage
The reported financial leverage ratio remained relatively stable over the five-year duration, fluctuating within a narrow range between 3.10 and 3.35. This suggests a consistent approach to total asset financing relative to reported equity.
Adjusted Financial Leverage Analysis
The transition to negative adjusted shareholders' equity fundamentally alters the leverage profile. Because the adjusted equity is negative, the adjusted financial leverage indicates a state where tangible assets are insufficient to cover total liabilities. The widening negative gap in adjusted equity from 2020 to 2024 suggests an increasing reliance on intangible valuations to maintain a positive reported equity position.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?


Adjusted Return on Equity (ROE)

Microsoft Excel
Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
As Reported
Selected Financial Data (US$ in millions)
Net income attributable to CVS Health 4,614 8,344 4,149 7,910 7,179
Total CVS Health shareholders’ equity 75,560 76,461 71,015 75,075 69,389
Profitability Ratio
ROE1 6.11% 10.91% 5.84% 10.54% 10.35%
Adjusted for Goodwill
Selected Financial Data (US$ in millions)
Adjusted net income attributable to CVS Health 4,614 8,344 4,149 8,341 7,179
Adjusted total CVS Health shareholders’ equity (15,712) (14,811) (7,135) (4,046) (10,163)
Profitability Ratio
Adjusted ROE2 — — — — —

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

2024 Calculations

1 ROE = 100 × Net income attributable to CVS Health ÷ Total CVS Health shareholders’ equity
= 100 × 4,614 ÷ 75,560 = 6.11%

2 Adjusted ROE = 100 × Adjusted net income attributable to CVS Health ÷ Adjusted total CVS Health shareholders’ equity
= 100 × 4,614 ÷ -15,712 = —


The financial performance over the five-year period is characterized by significant volatility in net income and a stark divergence between reported and adjusted equity metrics. While reported shareholders' equity remained positive and relatively stable, adjusted equity was consistently negative, indicating that the value of goodwill and intangible assets exceeds the total reported equity of the organization.

Net Income Trends
Adjusted net income demonstrates a cyclical pattern, with a notable peak in 2023 at 8,344 million USD and significant contractions in 2022 (4,149 million USD) and 2024 (4,614 million USD). The close alignment between reported and adjusted net income suggests that non-recurring items had a minimal impact on the bottom line for most of the period.
Equity Divergence and Asset Composition
Reported shareholders' equity maintained a range between 69,389 million USD and 76,461 million USD. Conversely, adjusted equity remained negative throughout the entire duration, shifting from negative 10,163 million USD in 2020 to negative 15,712 million USD by 2024. This persistent negative adjusted equity reflects a balance sheet heavily weighted by intangible assets and goodwill, which are stripped out to arrive at the adjusted figure.
Return on Equity (ROE) Analysis
Reported ROE fluctuated in correlation with net income, peaking at 10.91% in 2023 and dropping to 5.84% in 2022. However, the negative values in adjusted equity render the reported ROE an incomplete measure of tangible performance. The absence of a positive adjusted ROE highlights that the company is generating earnings against a negative tangible book value, emphasizing the high premium paid for acquisitions and intangible assets relative to the total equity base.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?


Adjusted Return on Assets (ROA)

Microsoft Excel
Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
As Reported
Selected Financial Data (US$ in millions)
Net income attributable to CVS Health 4,614 8,344 4,149 7,910 7,179
Total assets 253,215 249,728 228,275 232,999 230,715
Profitability Ratio
ROA1 1.82% 3.34% 1.82% 3.39% 3.11%
Adjusted for Goodwill
Selected Financial Data (US$ in millions)
Adjusted net income attributable to CVS Health 4,614 8,344 4,149 8,341 7,179
Adjusted total assets 161,943 158,456 150,125 153,878 151,163
Profitability Ratio
Adjusted ROA2 2.85% 5.27% 2.76% 5.42% 4.75%

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

2024 Calculations

1 ROA = 100 × Net income attributable to CVS Health ÷ Total assets
= 100 × 4,614 ÷ 253,215 = 1.82%

2 Adjusted ROA = 100 × Adjusted net income attributable to CVS Health ÷ Adjusted total assets
= 100 × 4,614 ÷ 161,943 = 2.85%


The financial trajectory from 2020 to 2024 is characterized by significant volatility in net income and a substantial disparity between reported and adjusted asset valuations. The presence of considerable goodwill and intangible assets creates a distinct gap between reported performance metrics and those adjusted to reflect core tangible assets.

Profitability Trends
Net income exhibits a fluctuating pattern over the analyzed period. Adjusted net income peaked in 2021 at US$ 8,341 million and again in 2023 at US$ 8,344 million. Conversely, significant contractions occurred in 2022 and 2024, with adjusted net income falling to US$ 4,149 million and US$ 4,614 million, respectively. These fluctuations directly correlate with the volatility observed in the return on assets.
Asset Base Composition
A persistent variance is observed between reported total assets and adjusted total assets. By December 31, 2024, reported assets reached US$ 253,215 million, while adjusted assets were US$ 161,943 million. This consistent difference indicates that a significant portion of the balance sheet is comprised of goodwill and intangible assets, which are excluded from the adjusted asset calculation to provide a clearer view of tangible resource utilization.
Adjusted Return on Assets (ROA) Analysis
Adjusted ROA consistently exceeds reported ROA throughout the five-year period, indicating that the company's core tangible assets generate a higher rate of return than the total asset base. Adjusted ROA reached a maximum of 5.42% in 2021 and recovered to 5.27% in 2023, following a sharp decline to 2.76% in 2022. By December 31, 2024, the adjusted ROA stood at 2.85%, mirroring the overall trend of net income volatility while remaining higher than the reported ROA of 1.82%.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?